Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.68bn | 1.69bn | 1.80bn | 1.75bn | 1.61bn | 1.69bn | 1.71bn | 1.72bn |
| Cost of revenue | 1.08bn | 1.10bn | 1.18bn | 1.14bn | 1.07bn | 1.14bn | 1.13bn | 1.13bn |
| Research and development | 47m | — | 140m | 142m | 137m | — | 127m | 134m |
| Selling, general and administrative | 255m | — | 387m | 405m | 369m | — | 368m | 418m |
| Pre-tax income | 181m | −66m | 91m | 78m | 97m | −199m | 287m | 1m |
| Income tax | 31m | — | 19m | 68m | 119m | — | 99m | 120m |
| Net income | 161m | −126m | −123m | 59m | −589m | −117m | 454m | 178m |
| Earnings per share | 0.39 | −0.30 | −0.29 | 0.14 | −1.41 | −0.28 | 1.09 | 0.43 |
| Earnings per share, diluted | 0.39 | −0.30 | −0.29 | 0.14 | −1.40 | −0.28 | 1.08 | 0.43 |
| Weighted average shares | 410m | — | 419m | 419m | 419m | — | 418m | 418m |
| Weighted average shares, diluted | 413m | — | 420m | 420m | 419m | — | 420m | 419m |
| Metric | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 710m | 715m | 1.96bn | 1.84bn | 1.76bn | 1.79bn | 1.68bn | 1.51bn |
| Receivables | 1.70bn | 1.67bn | 2.37bn |
| Metric | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 232m | — | — | 382m | — | — |
| Depreciation and amortisation | 155m | 257m | 296m | 293m |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)
| 2.54bn |
| 2.29bn |
| 1.34bn |
| 2.36bn |
| 2.31bn |
| Inventory | 1.21bn | 1.17bn | 1.84bn | 2.30bn | 2.24bn | 1.13bn | 2.24bn | 2.16bn |
| Current assets | 5.64bn | 5.58bn | 10.02bn | 6.85bn | 6.46bn | 20.78bn | 6.44bn | 6.16bn |
| Goodwill | 7.87bn | 7.92bn | 16.22bn | 16.24bn | 15.95bn | 7.56bn | 16.87bn | 16.56bn |
| Total assets | 21.45bn | 21.58bn | 38.04bn | 36.56bn | 35.98bn | 36.64bn | 37.46bn | 36.55bn |
| Current liabilities | 2.10bn | 2.31bn | 5.01bn | 4.85bn | 4.63bn | 5.50bn | 2.83bn | 2.79bn |
| Short-term debt | 40m | 60m | 1.85bn | 1.85bn | 1.85bn | 1.85bn | — | — |
| Long-term debt | 3.13bn | 3.13bn | 7.05bn | 5.33bn | 5.33bn | 5.32bn | 7.17bn | 7.17bn |
| Total liabilities | 7.21bn | 7.47bn | 14.70bn | 13.04bn | 12.71bn | 12.84bn | 12.80bn | 12.79bn |
| Equity | 14.04bn | 13.92bn | 22.89bn | 23.52bn | 23.27bn | 23.35bn | 24.66bn | 23.76bn |
| Shares outstanding | — | 409m | 419m | 419m | 418m | 418m | 418m | 417m |
| Shares issued | 410m | 409m | 419m | 419m | 418m | 418m | 418m | 417m |
| 267m |
| 298m |
| Share-based compensation | 13m | — | — | 12m | — | — |
| Capital expenditure | 102m | — | — | 249m | — | — |
| Investing cash flow | −102m | — | — | −247m | — | — |
| Dividends paid | 82m | — | — | 172m | — | — |
| Financing cash flow | −44m | — | — | −206m | — | — |